NCT02658214 2020-08-20
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
AstraZeneca
Phase 1 Completed
AstraZeneca
Daiichi Sankyo
NYU Langone Health
The University of Texas Health Science Center, Houston